These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 31346129)
1. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129 [TBL] [Abstract][Full Text] [Related]
2. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623 [TBL] [Abstract][Full Text] [Related]
3. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455 [TBL] [Abstract][Full Text] [Related]
4. Astroblastoma With a Novel YAP1::BEND2 Fusion: A Case Report. Cuoco JA; Williams S; Klein BJ; Borowicz VM; Ho H; Stump MS; Rogers CM J Pediatr Hematol Oncol; 2024 Jul; 46(5):e313-e316. PubMed ID: 38857191 [TBL] [Abstract][Full Text] [Related]
5. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. Lehman NL J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386 [TBL] [Abstract][Full Text] [Related]
6. Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. Lehman NL; Hattab EM; Mobley BC; Usubalieva A; Schniederjan MJ; McLendon RE; Paulus W; Rushing EJ; Georgescu MM; Couce M; Dulai MS; Cohen ML; Pierson CR; Raisanen JM; Martin SE; Lehman TD; Lipp ES; Bonnin JM; Al-Abbadi MA; Kenworthy K; Zhao K; Mohamed N; Zhang G; Zhao W Neuro Oncol; 2017 Jan; 19(1):31-42. PubMed ID: 27416954 [TBL] [Abstract][Full Text] [Related]
7. BRAF V600E-mutated central nervous system tumor with divergent morphological feature - Anaplastic pleomorphic xanthoastrocytoma-like and astroblastoma-like. Purkait S; Bansal S; Malgulwar PB Neuropathology; 2019 Feb; 39(1):64-67. PubMed ID: 30557911 [TBL] [Abstract][Full Text] [Related]
8. Recurrent high-grade astroblastoma with Sun D; Liu J; Xiao L; Guan H Clin Neuropathol; 2023; 42(1):30-39. PubMed ID: 36366964 [TBL] [Abstract][Full Text] [Related]